Ligand validation:3VJK

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 3VJK designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3VJK_NAG_B_1085	54%	40%	0.104	0.866	0.5	1.8	-	3	0	0	100%	0.9333
3VJK_NAG_A_1085	47%	44%	0.124	0.861	0.51	1.62	-	1	0	0	100%	0.9333
3VJK_NAG_B_1281	28%	38%	0.131	0.779	0.6	1.78	-	4	0	0	100%	0.9333
3VJK_NAG_B_1150	24%	51%	0.204	0.833	0.42	1.43	-	1	0	0	100%	0.9333
3VJK_NAG_A_1321	12%	38%	0.258	0.785	0.6	1.8	-	3	0	0	100%	0.9333
3VJK_NAG_A_1092	11%	16%	0.242	0.759	0.64	2.98	-	6	0	0	100%	0.9333
3VJK_NAG_B_1321	9%	57%	0.275	0.771	0.61	1.03	-	1	0	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
3NOX_NAG_A_851	94%	61%	0.07	0.971	0.58	0.91	-	-	0	0	100%	0.9333
3SWW_NAG_A_851	89%	58%	0.082	0.962	0.65	0.94	-	-	0	0	100%	0.9333
3OC0_NAG_A_794	89%	35%	0.076	0.953	0.76	1.76	-	6	0	0	100%	0.9333
4N8E_NAG_B_804	87%	63%	0.073	0.944	0.29	1.12	-	3	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333
3GXM_NAG_A_498	100%	45%	0.026	0.992	0.75	1.34	-	2	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.